Evidence map›Paper›PMID 26121537›Full record

ArticleJAMA internal medicine2015

Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for Individual Residents.

Nick Daneman, Susan E Bronskill, Andrea Gruneir, Alice M Newman, Hadas D Fischer, Paula A Rochon, Geoffrey M Anderson, Chaim M Bell

Abstract read
PubMed Publisher
In one paragraph

Article in JAMA internal medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Global burden ofJournal of global health · 2019
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Canadian nurses' perspectives on challenges to antimicrobial stewardship in long-term care homes.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026
    Review
  9. Visible-light driven multifunctional CaPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  10. Institutional spillover effects of antimicrobial use on antimicrobial resistance andAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Penicillin allergy delabeling in long-term care facilities: if not now, then when?Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Nick DanemanInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada2Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada3Institute of Health Policy, Management and Eva.
Susan E BronskillInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Andrea GruneirInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Women's College Research Institute, Women's College Hospital, University of Toronto.
Alice M NewmanInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Hadas D FischerInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Paula A RochonInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Women's College Research Institute, Women's College Hospital, University of Toronto.
Geoffrey M AndersonInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Chaim M BellInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada6Division of General Internal Medicine, Mount Sinai Hospital, University of Toronto.

Funding

Canadian Institutes of Health Research OTG-88591
6 · The paper itself

Abstract

importanceAntibiotics are frequently and often inappropriately prescribed to patients in nursing homes. These antibiotics pose direct risks to recipients and indirect risks to others residing in the home.

objectiveTo examine whether living in a nursing home with high antibiotic use is associated with an increased risk of antibiotic-related adverse outcomes for individual residents. DESIGN, SETTING, AND

participantsIn this longitudinal open-cohort study performed from January 1, 2010, through December 31, 2011, we studied 110,656 older adults residing in 607 nursing homes in Ontario, Canada. EXPOSURES: Nursing home-level antibiotic use was defined as use-days per 1000 resident-days, and facilities were classified as high, medium, and low use according to tertile of use. Multivariable logistic regression modeling was performed to assess the effect of nursing home-level antibiotic use on the individual risk of antibiotic-related adverse outcomes. MAIN OUTCOMES AND MEASURES: Antibiotic-related harms included Clostridium difficile, diarrhea or gastroenteritis, antibiotic-resistant organisms (which can directly affect recipients and indirectly affect nonrecipients), allergic reactions, and general medication adverse events (which can affect only recipients).

resultsAntibiotics were provided on 2,783,000 of 50,953,000 resident-days in nursing homes (55 antibiotic-days per 1000 resident-days). Antibiotic use was highly variable across homes, ranging from 20.4 to 192.9 antibiotic-days per 1000 resident-days. Antibiotic-related adverse events were more common (13.3%) in residents of high-use homes than among residents of medium-use (12.4%) or low-use homes (11.4%) (P < .001); this trend persisted even among the residents who did not receive antibiotic treatments. The primary analysis indicated that residence in a high-use nursing home was associated with an increased risk of a resident experiencing an antibiotic-related adverse event (adjusted odds ratio, 1.24; 95% CI, 1.07-1.42; P = .003). A sensitivity analysis examining nursing home-level antibiotic use as a continuous variable confirmed an increased risk of resident-level antibiotic-related harms (adjusted odds ratio, 1.004 per additional day of nursing home antibiotic use; 95% CI, 1.001-1.006; P = .01). CONCLUSIONS AND RELEVANCE: Antibiotic use is highly variable across nursing homes; residents of high-use homes are exposed to an increased risk of antibiotic-related harms even if they have not directly received these agents. Antibiotic stewardship is needed to improve the safety of all nursing home residents.

Indexed as

Homes for the AgedNursing HomesAgedAged, 80 and overAnti-Bacterial AgentsCohort StudiesDiarrheaDrug HypersensitivityDrug Resistance, BacterialEnterocolitis, PseudomembranousFemaleGastroenteritisHumansLogistic ModelsLongitudinal StudiesMaleAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.